Related Experiment Video
Updated: Jun 9, 2026
05:35
A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
Published on: January 19, 2024
Anemia in older persons.
Michael H Bross1, Kathleen Soch, Teresa Smith-Knuppel
1University of Colorado Denver School of Medicine, Aurora, Colorado, USA. michael.bross@ucdenver.edu
American Family Physician
|September 9, 2010
Summary
Anemia in older adults is often missed but linked to worse health outcomes. Evaluation is crucial, as causes range from nutritional deficiencies to chronic diseases, with varying treatment effectiveness.
Area of Science:
- Gerontology
- Hematology
- Internal Medicine
Background:
- Anemia in older adults (hemoglobin <13g/dL men, <12g/dL women) affects over 10% of those >65.
- Prevalence increases with age, reaching 50% in nursing home residents.
- Even mild anemia is linked to increased morbidity and mortality.
Purpose of the Study:
- To highlight the significance of anemia in older persons.
- To discuss the prevalence, causes, and management of anemia in this demographic.
- To emphasize the need for evaluation and appropriate interventions.
Main Methods:
- Review of World Health Organization definition of anemia.
- Categorization of anemia causes: nutritional deficiency, chronic inflammation/kidney disease, unexplained.
- Discussion of treatment strategies for different anemia types.
Main Results:
- Approximately one-third of anemia cases are due to nutritional deficiencies.
- Another third result from chronic inflammation or chronic kidney disease.
- The remaining third are unexplained, posing treatment challenges.
Conclusions:
- Anemia evaluation is recommended for most older individuals.
- Nutritional anemias are treatable with replacement therapy.
- Anemia of chronic disease/kidney disease may improve with underlying condition management and erythropoiesis-stimulating agents.
- Treatment for unexplained anemia lacks strong evidence for improving outcomes or quality of life.
- Less common causes like autoimmune hemolytic anemia, malignancy, or myelodysplastic syndrome require specific investigation.
Related Concept Videos
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...